Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation

Optimal antithrombotic treatment of older patients is usually impeded by several prevailing misconceptions. The aim of our study was to assess the type, dosage and predictors of antithrombotic therapy in older patients with non-valvular atrial fibrillation (NVAF). PAVE-AF was a prospective, cross-se...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzeis, Stylianos, Savvari, Paraskevi, Skiadas, Ioannis, Patsilinakos, Sotirios, Stamatelopoulos, Kimon, Kourouklis, Spyridon, Kyrikos, Sotirios, Tsatiris, Konstantinos, Menegas, Damianos, Hahalis, George, Giannakoulas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829237/
https://www.ncbi.nlm.nih.gov/pubmed/32519166
http://dx.doi.org/10.1007/s11239-020-02167-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829237/
https://www.ncbi.nlm.nih.gov/pubmed/32519166
http://dx.doi.org/10.1007/s11239-020-02167-8

Ejemplares similares